Elizabeth Plimack
MD, MS
Chief, GU Medical Oncology
👥Biography 个人简介
Elizabeth Plimack has been a pioneer in neoadjuvant immunotherapy for muscle-invasive bladder cancer and a key investigator in enfortumab vedotin trials. Her PURE-01 collaborations and other studies have advanced perioperative treatment approaches. She leads translational biomarker research to predict immunotherapy and ADC response in urothelial cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Elizabeth Plimack 的研究动态
Follow Elizabeth Plimack's research updates
留下邮箱，当我们发布与 Elizabeth Plimack（Fox Chase Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment